| Primary |
| Plasma Cell Myeloma |
78.6% |
| Myelodysplastic Syndrome |
11.8% |
| Chronic Lymphocytic Leukaemia |
1.7% |
| Product Used For Unknown Indication |
1.7% |
| Lymphoma |
1.3% |
| Amyloidosis |
0.9% |
| Myelofibrosis |
0.9% |
| Non-hodgkin's Lymphoma |
0.9% |
| 5Q Minus Syndrome |
0.4% |
| B-cell Lymphoma |
0.4% |
| Ear Discomfort |
0.4% |
| Lymphocytic Lymphoma |
0.4% |
| Myeloid Leukaemia |
0.4% |
|
| White Blood Cell Count Decreased |
12.9% |
| Pneumonia |
11.4% |
| Thrombosis |
10.6% |
| Rash |
6.8% |
| Platelet Count Decreased |
6.1% |
| Neutropenia |
4.5% |
| Pancytopenia |
4.5% |
| Plasma Cell Myeloma |
4.5% |
| Renal Failure |
4.5% |
| Diarrhoea |
3.8% |
| Oedema Peripheral |
3.8% |
| Pruritus |
3.8% |
| Pyrexia |
3.8% |
| Fatigue |
3.0% |
| Full Blood Count Decreased |
3.0% |
| Rash Pruritic |
3.0% |
| Renal Impairment |
3.0% |
| Anaemia |
2.3% |
| Drug Ineffective |
2.3% |
| Muscle Spasms |
2.3% |
|
| Secondary |
| Plasma Cell Myeloma |
83.3% |
| Myelodysplastic Syndrome |
16.7% |
|
| Platelet Count Decreased |
33.3% |
| Toothache |
22.2% |
| Neutrophil Count Decreased |
11.1% |
| Plasma Cell Myeloma |
11.1% |
| Renal Failure |
11.1% |
| Renal Failure Acute |
11.1% |
|
| Concomitant |
| Blood Iron Increased |
20.0% |
| Product Used For Unknown Indication |
20.0% |
| Prophylaxis Against Gastrointestinal Ulcer |
20.0% |
| Prostate Cancer |
20.0% |
| Transfusion |
20.0% |
|
| Electrocardiogram Qt Prolonged |
16.7% |
| Pain In Jaw |
16.7% |
| Serum Ferritin Increased |
16.7% |
| Stomach Discomfort |
16.7% |
| Urticaria |
16.7% |
| Ventricular Tachycardia |
16.7% |
|
